The U.S. Food and Drug Administration approved dupilumab for eosinophilic esophagitis in patients 12 and up in May 2022. This… Read more »
Tag: Dupixent
Dupilumab Shows Success in EoE, Leading to Hopes for Approval
EoE patients on the biologic drug dupilumab in a Phase 3 trial showed significant symptom improvement by six months of… Read more »
AAAAI News: Dupilumab Remission; Tezepelumab in Severe Asthma; Palforzia Safety
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
Allergy News: Dupilumab in Asthma and EoE, Targeted Asthma Inhalers
Dupilumab Reduced Severe Asthma in Children The biologic drug dupilumab markedly improved lung function while also reducing severe asthma attacks… Read more »
FARE Retreat: Experts Explore Food Allergy Treatment, Testing
“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
FDA Approves “Life-Changing” Biologic Drug Dupilumab for Adolescents with Severe Eczema
Painful, red eczema patches used to run up and down Benjamin Sun’s arms and legs. This severe atopic dermatitis led… Read more »
Biologic Drug Reduced Flare-Ups for Patients with Difficult Asthma
Patients with moderate-to-severe asthma who are struggling with disease control may find relief with the biologic medication called Dupixent (dupilumab).… Read more »
Breakthrough Therapy Changing the Lives of Those With Eczema
A physician and a new biologic drug have been freeing eczema patients of endless itch. Since this article first appeared… Read more »
Hope for Eczema Drug Ranges From Asthma to Food Allergies
This is a sidebar to Allergic Living’s feature: Breakthrough Therapy Changing the Lives of Those Living With Eczema. Dupilumab is… Read more »